Editas Medicine(EDIT) - 2026 Q1 - Quarterly Report
Editas MedicineEditas Medicine(US:EDIT)2026-05-06 04:16

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _______________________________ FORM 10-Q _______________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ________ Commission File Number 001-37687 __________________ ...

Editas Medicine(EDIT) - 2026 Q1 - Quarterly Report - Reportify